Company / Working Capital per Share
Seres Therapeutics, Inc. Working Capital per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$3.47
FY2025
5-year range
$0.87 / $3.47
FY2021-FY2025
Trend
+298.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share changed +299% YoY in FY2025, a notable deviation from the 9-year average annual change of +19%.
Based on SEC 10-K filings.
3.47 in FY2025 with a 10-year CAGR of -19.0%.
Improved from $1.19 to $3.47 over the past 3 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +43.0%
- 5-Year CAGR
- +1.8%
- 10-Year CAGR
- -19.0%
Key checks
Key Insights
- In FY2025, working capital per share increased 298.5% year-over-year.
- Peak working capital per share was recorded in FY2015.
- Lowest working capital per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.18 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.47 | +298.5% |
| FY2023 | $0.87 | -26.6% |
| FY2022 | $1.19 | -50.9% |
| FY2021 | $2.42 | -23.6% |
| FY2020 | $3.17 | +139.5% |
| FY2019 | $1.32 | +6.1% |
| FY2018 | $1.25 | -59.2% |
| FY2017 | $3.06 | -28.8% |
| FY2016 | $4.30 | -84.9% |
| FY2015 | $28.55 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 24, 2026